<li>acebutolol<p>acebutolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>acebutolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>aceclofenac<p>aceclofenac increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and aceclofenac both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>acemetacin<p>acemetacin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and acemetacin both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>albiglutide<p>hydrochlorothiazide decreases effects of albiglutide by pharmacodynamic antagonism. Use Caution/Monitor. Thiazide diuretics can decrease insulin sensitivity thereby leading to glucose intolerance and hyperglycemia. Monitor glycemic control especially when initiating, discontinuing, or increasing thiazide diuretic dose.</p></li><li>albuterol<p>triamterene increases and albuterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>albuterol<p>albuterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>aldesleukin<p>aldesleukin increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.<span><br><br></span>aldesleukin increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.</p></li><li>amantadine<p>triamterene increases levels of amantadine by decreasing elimination. Use Caution/Monitor.</p></li><li>amifostine<p>amifostine increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.</p></li><li>amifostine<p>amifostine increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.</p></li><li>amiloride<p>amiloride increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>amiodarone<p>amiodarone will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.<span><br><br></span>amiodarone will increase the level or effect of hydrochlorothiazide by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>amoxicillin<p>amoxicillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>amphetamine<p>amphetamine decreases effects of triamterene by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>amphetamine<p>amphetamine decreases effects of hydrochlorothiazide by pharmacodynamic antagonism. Use Caution/Monitor.</p></li><li>arformoterol<p>arformoterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and arformoterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>aspirin<p>aspirin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and aspirin both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>aspirin rectal<p>triamterene and aspirin rectal both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>aspirin rectal increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>aspirin/citric acid/sodium bicarbonate<p>aspirin/citric acid/sodium bicarbonate increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and aspirin/citric acid/sodium bicarbonate both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>atenolol<p>atenolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>atenolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>avanafil<p>avanafil increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.<span><br><br></span>avanafil increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.</p></li><li>bambuterol<p>triamterene increases and bambuterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>bambuterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>beclomethasone, inhaled<p>beclomethasone, inhaled increases toxicity of hydrochlorothiazide by increasing elimination. Use Caution/Monitor. May increase the hypokalemic effects of thiazide diuretics.</p></li><li>benazepril<p>benazepril and triamterene both increase  serum potassium. Use Caution/Monitor.</p></li><li>benazepril<p>benazepril increases toxicity of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Enhanced hypotensive effects; increased risk of nephrotoxicity.</p></li><li>bendroflumethiazide<p>triamterene increases and bendroflumethiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>bendroflumethiazide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>betaxolol<p>betaxolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>betaxolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>bisoprolol<p>bisoprolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>bisoprolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>bumetanide<p>triamterene increases and bumetanide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>bumetanide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>calcifediol<p>hydrochlorothiazide increases toxicity of calcifediol by Other (see comment). Use Caution/Monitor. 
Comment: Thiazide diuretics may increase serum calcium by decreasing urinary calcium excretion.</p></li><li>canagliflozin<p>triamterene and canagliflozin both increase  serum potassium. Use Caution/Monitor.</p></li><li>candesartan<p>candesartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>candesartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>captopril<p>captopril, triamterene.
Either increases toxicity of the other by Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Both drugs lower blood pressure. Increased risk of hyperkalemia. Monitor blood pressure and potassium.<span><br><br></span>captopril, hydrochlorothiazide.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Both drugs lower blood pressure. Increased risk of nephrotoxicity. Monitor blood pressure and renal function.</p></li><li>carbenoxolone<p>hydrochlorothiazide and carbenoxolone both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and carbenoxolone decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>carbidopa<p>carbidopa increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Therapy with carbidopa, given with or without levodopa or carbidopa-levodopa combination products, is started, dosage adjustment of the antihypertensive drug may be required.<span><br><br></span>carbidopa increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Therapy with carbidopa, given with or without levodopa or carbidopa-levodopa combination products, is started, dosage adjustment of the antihypertensive drug may be required.</p></li><li>carvedilol<p>carvedilol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>carvedilol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>cefprozil<p>hydrochlorothiazide will increase the level or effect of cefprozil by  acidic (anionic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>celecoxib<p>triamterene and celecoxib both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>celecoxib<p>celecoxib increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>celiprolol<p>celiprolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>hydrochlorothiazide decreases levels of celiprolol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.<span><br><br></span>celiprolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>chlorothiazide<p>chlorothiazide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and chlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>chlorthalidone<p>triamterene increases and chlorthalidone decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>chlorthalidone and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>cholestyramine<p>cholestyramine decreases levels of hydrochlorothiazide by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.</p></li><li>choline magnesium trisalicylate<p>triamterene and choline magnesium trisalicylate both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>citalopram<p>hydrochlorothiazide, citalopram. pharmacodynamic synergism. Use Caution/Monitor. Possible additive hyponatremia.</p></li><li>cornsilk<p>cornsilk increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).</p></li><li>corticotropin<p>corticotropin increases toxicity of hydrochlorothiazide by increasing renal clearance. Use Caution/Monitor. May enhance hypokalemic effect of thiazide diuretics.</p></li><li>cyclopenthiazide<p>cyclopenthiazide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and cyclopenthiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>cyclosporine<p>cyclosporine increases toxicity of hydrochlorothiazide by unspecified interaction mechanism. Use Caution/Monitor. Increases risk of hyperuricemia and gout-type complications.</p></li><li>dichlorphenamide<p>dichlorphenamide, triamterene.
Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Both drugs can cause metabolic acidosis.</p></li><li>deflazacort<p>hydrochlorothiazide and deflazacort both decrease  serum potassium. Use Caution/Monitor.</p></li><li>diazoxide<p>hydrochlorothiazide increases toxicity of diazoxide by unspecified interaction mechanism. Use Caution/Monitor. May enhance hyperglycemic effects of diazoxide.</p></li><li>dichlorphenamide<p>dichlorphenamide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>diclofenac<p>diclofenac increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and diclofenac both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>dicloxacillin<p>dicloxacillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>diflunisal<p>triamterene and diflunisal both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>diflunisal<p>diflunisal increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>digoxin<p>triamterene and digoxin both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>digoxin will increase the level or effect of hydrochlorothiazide by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.<span><br><br></span>digoxin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>digoxin will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.<span><br><br></span>hydrochlorothiazide increases effects of digoxin by pharmacodynamic synergism. Use Caution/Monitor. Hypokalemia increases digoxin effects.</p></li><li>disopyramide<p>triamterene increases effects of disopyramide by pharmacodynamic synergism. Use Caution/Monitor. Additive cardiovascular depression.</p></li><li>dobutamine<p>dobutamine and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>dobutamine<p>triamterene increases and dobutamine decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>dofetilide<p>dofetilide will increase the level or effect of hydrochlorothiazide by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.<span><br><br></span>dofetilide will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>dopexamine<p>triamterene increases and dopexamine decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>dopexamine and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>drospirenone<p>drospirenone increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>empagliflozin<p>empagliflozin, triamterene.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration of empagliflozin with diuretics results in increased urine volume and frequency of voids, which might enhance the potential for volume depletion.</p></li><li>empagliflozin<p>empagliflozin, hydrochlorothiazide.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration of empagliflozin with diuretics results in increased urine volume and frequency of voids, which might enhance the potential for volume depletion.</p></li><li>enalapril<p>enalapril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>ephedrine<p>triamterene increases and ephedrine decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>ephedrine and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>ephedrine (pulmonary)<p>ephedrine (pulmonary) and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and ephedrine (pulmonary) decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.  .</p></li><li>epinephrine<p>triamterene increases and epinephrine decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>epinephrine and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>epinephrine racemic<p>epinephrine racemic and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and epinephrine racemic decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>eprosartan<p>eprosartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>eprosartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>esmolol<p>esmolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>esmolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ethacrynic acid<p>ethacrynic acid and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and ethacrynic acid decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>etodolac<p>triamterene and etodolac both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>etodolac increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>etoricoxib<p>etoricoxib increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and etoricoxib both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>exenatide injectable solution<p>hydrochlorothiazide decreases effects of exenatide injectable solution by pharmacodynamic antagonism. Use Caution/Monitor. Thiazide diuretics can decrease insulin sensitivity thereby leading to glucose intolerance and hyperglycemia. Monitor glycemic control especially when initiating, discontinuing, or increasing thiazide diuretic dose.</p></li><li>fenbufen<p>triamterene and fenbufen both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>exenatide injectable suspension<p>hydrochlorothiazide decreases effects of exenatide injectable suspension by pharmacodynamic antagonism. Use Caution/Monitor. Thiazide diuretics can decrease insulin sensitivity thereby leading to glucose intolerance and hyperglycemia. Monitor glycemic control especially when initiating, discontinuing, or increasing thiazide diuretic dose.</p></li><li>fenbufen<p>fenbufen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fenoprofen<p>fenoprofen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and fenoprofen both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>fentanyl<p>fentanyl decreases effects of triamterene by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).<span><br><br></span>fentanyl decreases effects of hydrochlorothiazide by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).</p></li><li>fentanyl intranasal<p>fentanyl intranasal decreases effects of triamterene by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).<span><br><br></span>fentanyl intranasal decreases effects of hydrochlorothiazide by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).</p></li><li>fentanyl iontophoretic transdermal system<p>fentanyl iontophoretic transdermal system decreases effects of triamterene by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).<span><br><br></span>fentanyl iontophoretic transdermal system decreases effects of hydrochlorothiazide by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).</p></li><li>fentanyl transdermal<p>fentanyl transdermal decreases effects of hydrochlorothiazide by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).<span><br><br></span>fentanyl transdermal decreases effects of triamterene by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).</p></li><li>fentanyl transmucosal<p>fentanyl transmucosal decreases effects of triamterene by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).<span><br><br></span>fentanyl transmucosal decreases effects of hydrochlorothiazide by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: Fentanyl can reduce the efficacy of diuretics by inducing antidiuretic hormone release. Fentanyl may also lead to acute urinary retention by causing bladder sphincter spasm (particularly in men with enlarged prostates).</p></li><li>flucloxacillin<p>flucloxacillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.<span><br><br></span>flucloxacillin increases effects of triamterene by unspecified interaction mechanism. Use Caution/Monitor. Hyperkalemia.</p></li><li>flurbiprofen<p>triamterene and flurbiprofen both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>flurbiprofen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>formoterol<p>formoterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and formoterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>fosinopril<p>fosinopril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>furosemide<p>furosemide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>furosemide<p>triamterene increases and furosemide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>gentamicin<p>triamterene increases and gentamicin decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>hydrochlorothiazide and gentamicin both decrease  serum potassium. Use Caution/Monitor.</p></li><li>hydrochlorothiazide<p>triamterene increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>ibuprofen<p>ibuprofen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ibuprofen<p>triamterene and ibuprofen both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>imidapril<p>imidapril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>indacaterol, inhaled<p>hydrochlorothiazide, indacaterol, inhaled. serum potassium. Use Caution/Monitor. Combination may increase risk of hypokalemia.<span><br><br></span>indacaterol, inhaled, hydrochlorothiazide. Other (see comment). Use Caution/Monitor. 
Comment: Caution is advised in the coadministration of indacaterol neohaler with non-potassium-sparing diuretics.</p></li><li>indapamide<p>triamterene increases and indapamide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>hydrochlorothiazide and indapamide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>indomethacin<p>triamterene and indomethacin both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>indomethacin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>insulin degludec<p>hydrochlorothiazide decreases effects of insulin degludec by Other (see comment). Use Caution/Monitor. 
Comment: Diuretics may cause hyperglycemia and glycosuria in patients with diabetes mellitus, possibly by diuretic-induced hpokalemia.</p></li><li>irbesartan<p>irbesartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>insulin degludec/insulin aspart<p>hydrochlorothiazide decreases effects of insulin degludec/insulin aspart by Other (see comment). Use Caution/Monitor. 
Comment: Diuretics may cause hyperglycemia and glycosuria in patients with diabetes mellitus, possibly by diuretic-induced hpokalemia.</p></li><li>insulin inhaled<p>hydrochlorothiazide decreases effects of insulin inhaled by Other (see comment). Use Caution/Monitor. 
Comment: Diuretics may cause hyperglycemia and glycosuria in patients with diabetes mellitus, possibly by diuretic-induced hpokalemia.</p></li><li>irbesartan<p>irbesartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>isoproterenol<p>triamterene increases and isoproterenol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>isoproterenol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>juniper<p>juniper, triamterene. Other (see comment). Use Caution/Monitor. 
Comment: Juniper may potentiate or interfere with diuretic therapy. Juniper has diuretic effects, but may cause kidney damage at large doses.<span><br><br></span>juniper, hydrochlorothiazide. Other (see comment). Use Caution/Monitor. 
Comment: Juniper may potentiate or interfere with diuretic therapy. Juniper has diuretic effects, but may cause kidney damage at large doses.</p></li><li>ketoprofen<p>triamterene and ketoprofen both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>ketoprofen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ketorolac<p>triamterene and ketorolac both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>ketorolac increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ketorolac intranasal<p>triamterene and ketorolac intranasal both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>ketorolac intranasal increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>labetalol<p>labetalol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>labetalol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>levalbuterol<p>levalbuterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and levalbuterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>levodopa<p>levodopa increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Consider decreasing dosage of antihypertensive agent.<span><br><br></span>levodopa increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Consider decreasing dosage of antihypertensive agent.</p></li><li>lily of the valley<p>hydrochlorothiazide increases toxicity of lily of the valley by Other (see comment). Use Caution/Monitor. 
Comment: Increased risk of cardiac toxicity due to K+ depletion.</p></li><li>lisinopril<p>lisinopril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>liraglutide<p>hydrochlorothiazide decreases effects of liraglutide by pharmacodynamic antagonism. Use Caution/Monitor. Thiazide diuretics can decrease insulin sensitivity thereby leading to glucose intolerance and hyperglycemia. Monitor glycemic control especially when initiating, discontinuing, or increasing thiazide diuretic dose.</p></li><li>lithium<p>hydrochlorothiazide increases toxicity of lithium by decreasing elimination. Use Caution/Monitor.</p></li><li>lornoxicam<p>lornoxicam increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and lornoxicam both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>losartan<p>losartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>losartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>lurasidone<p>lurasidone increases effects of hydrochlorothiazide by Other (see comment). Use Caution/Monitor. 
Comment: Potential  for increased risk of hypotension with concurrent use. Monitor blood pressure and adjust  dose of  antihypertensive agent as needed.</p></li><li>maraviroc<p>maraviroc, triamterene.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of orthostatic hypotension.</p></li><li>maitake<p>maitake increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of hypokalemia (theoretical interaction).</p></li><li>meclofenamate<p>meclofenamate increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and meclofenamate both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>mefenamic acid<p>mefenamic acid increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and mefenamic acid both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>meloxicam<p>meloxicam increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and meloxicam both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>metaproterenol<p>triamterene increases and metaproterenol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>metaproterenol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>methoxsalen<p>methoxsalen, hydrochlorothiazide.
Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Additive photosensitizing effects.</p></li><li>methyclothiazide<p>triamterene increases and methyclothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.  .</p></li><li>metolazone<p>triamterene increases and metolazone decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>hydrochlorothiazide and metolazone both decrease  serum potassium. Use Caution/Monitor.</p></li><li>metoprolol<p>metoprolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>metoprolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>hydrochlorothiazide, metoprolol.
Either increases toxicity of the other by Other (see comment). Modify Therapy/Monitor Closely. 
Comment: May cause idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma, which can lead to permanent vision loss.</p></li><li>moexipril<p>moexipril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>mycophenolate<p>hydrochlorothiazide will increase the level or effect of mycophenolate by  acidic (anionic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>nabumetone<p>triamterene and nabumetone both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>nabumetone increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nadolol<p>nadolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>nadolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nafcillin<p>nafcillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>naproxen<p>triamterene and naproxen both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>naproxen<p>naproxen increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nebivolol<p>nebivolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>nebivolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>nitroglycerin rectal<p>nitroglycerin rectal, hydrochlorothiazide.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Observe for possible additive hypotensive effects during concomitant use. .<span><br><br></span>nitroglycerin rectal, triamterene.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Observe for possible additive hypotensive effects during concomitant use. .</p></li><li>noni juice<p>triamterene and noni juice both increase  serum potassium. Use Caution/Monitor.</p></li><li>norepinephrine<p>norepinephrine and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>norepinephrine<p>triamterene increases and norepinephrine decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>olmesartan<p>olmesartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>olmesartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>olodaterol inhaled<p>hydrochlorothiazide and olodaterol inhaled both decrease  serum potassium. Use Caution/Monitor.</p></li><li>oxaprozin<p>triamterene and oxaprozin both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>oxaprozin<p>oxaprozin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>parecoxib<p>parecoxib increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and parecoxib both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>penbutolol<p>penbutolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>penbutolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>penicillin g aqueous<p>penicillin g aqueous, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>perindopril<p>perindopril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>pindolol<p>pindolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>pindolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pirbuterol<p>pirbuterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and pirbuterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>piroxicam<p>triamterene and piroxicam both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>piroxicam increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pivmecillinam<p>pivmecillinam, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.<span><br><br></span>pivmecillinam increases effects of triamterene by unspecified interaction mechanism. Use Caution/Monitor. Hyperkalemia.</p></li><li>porfimer<p>hydrochlorothiazide, porfimer. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Enhanced photosensitivity.</p></li><li>potassium citrate/citric acid<p>triamterene and potassium citrate/citric acid both increase  serum potassium. Use Caution/Monitor.</p></li><li>potassium acid phosphate<p>potassium acid phosphate increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>potassium chloride<p>potassium chloride increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>potassium citrate<p>potassium citrate increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>probenecid<p>hydrochlorothiazide will increase the level or effect of probenecid by  acidic (anionic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>procainamide<p>procainamide will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.<span><br><br></span>hydrochlorothiazide will increase the level or effect of procainamide by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>propranolol<p>propranolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>propranolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>quinapril<p>quinapril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>quinidine<p>quinidine will increase the level or effect of hydrochlorothiazide by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>quinidine<p>quinidine will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Use Caution/Monitor.</p></li><li>ramipril<p>ramipril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>sacubitril/valsartan<p>sacubitril/valsartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>sacubitril/valsartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>salicylates (non-asa)<p>salicylates (non-asa) increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and salicylates (non-asa) both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>salmeterol<p>salmeterol and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.<span><br><br></span>triamterene increases and salmeterol decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>salsalate<p>salsalate increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and salsalate both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>shark cartilage<p>hydrochlorothiazide, shark cartilage. Other (see comment). Use Caution/Monitor. 
Comment: May lead to hypercalcemia (theoretical).</p></li><li>sotalol<p>sotalol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>sodium sulfate/potassium sulfate/magnesium sulfate<p>hydrochlorothiazide and sodium sulfate/potassium sulfate/magnesium sulfate both decrease  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol<p>hydrochlorothiazide and sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol both decrease  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>sotalol<p>sotalol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>spironolactone<p>spironolactone increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>succinylcholine<p>succinylcholine increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and succinylcholine both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>sulfasalazine<p>triamterene and sulfasalazine both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>sulfasalazine increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>sulindac<p>triamterene and sulindac both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>sulindac increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>tadalafil<p>tadalafil increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.<span><br><br></span>tadalafil increases effects of hydrochlorothiazide by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.</p></li><li>telmisartan<p>telmisartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.<span><br><br></span>telmisartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>temocillin<p>temocillin increases effects of triamterene by unspecified interaction mechanism. Use Caution/Monitor. Hyperkalemia.<span><br><br></span>temocillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>terbutaline<p>triamterene increases and terbutaline decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.<span><br><br></span>terbutaline and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>ticarcillin<p>ticarcillin increases effects of triamterene by unspecified interaction mechanism. Use Caution/Monitor. Hyperkalemia.<span><br><br></span>ticarcillin, hydrochlorothiazide.
Either increases levels of the other by decreasing renal clearance. Use Caution/Monitor.</p></li><li>timolol<p>timolol increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>timolol and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>tolfenamic acid<p>tolfenamic acid increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and tolfenamic acid both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>tolmetin<p>tolmetin increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and tolmetin both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>tolvaptan<p>tolvaptan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>triamterene and tolvaptan both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>toremifene<p>hydrochlorothiazide, toremifene. Other (see comment). Use Caution/Monitor. 
Comment: Thiazide diuretics decrease renal calcium excretion and may increase risk of hypercalcemia in patients taking toremifene.</p></li><li>torsemide<p>triamterene increases and torsemide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>torsemide<p>torsemide and hydrochlorothiazide both decrease  serum potassium. Use Caution/Monitor.</p></li><li>trandolapril<p>trandolapril, triamterene. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Risk of hyperkalemia.</p></li><li>triamterene<p>triamterene increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>trientine<p>hydrochlorothiazide decreases levels of trientine by increasing renal clearance. Use Caution/Monitor.</p></li><li>trimethoprim<p>trimethoprim and triamterene both increase  serum potassium. Use Caution/Monitor. Trimethoprim decreases urinary potassium excretion. May cause hyperkalemia, particularly with high doses, renal insufficiency, or when combined with other drugs that cause hyperkalemia.</p></li><li>umeclidinium bromide/vilanterol inhaled<p>umeclidinium bromide/vilanterol inhaled and hydrochlorothiazide both decrease  serum potassium. Modify Therapy/Monitor Closely. Electrocardiographic changes and/or hypokalemia associated with non–potassium-sparing diuretics may worsen with concomitant beta-agonists, particularly if recommended dose is exceeded</p></li><li>valsartan<p>valsartan increases and hydrochlorothiazide decreases serum potassium. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>valsartan and triamterene both increase  serum potassium. Modify Therapy/Monitor Closely.</p></li><li>vilanterol/fluticasone furoate inhaled<p>vilanterol/fluticasone furoate inhaled and hydrochlorothiazide both decrease  serum potassium. Modify Therapy/Monitor Closely. Beta-agonists may acutely worsen ECG changes and/or hypokalemia resulting from non-potassium-sparing diuretics </p></li><li>xipamide<p>xipamide increases effects of triamterene by pharmacodynamic synergism. Use Caution/Monitor.</p></li>